Pfizer (PFE) Selling, General & Administrative (2009 - 2026)
Powered by 
Analysis
Pfizer (PFE) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 3.41 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -2.87 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 110.21 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 351.74 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 206.70 Mn |
| 10 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 439.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 3.41 Bn |
| Mar 29, 2026 | 2.96 Bn |
| Dec 31, 2025 | 4.16 Bn |
| Sep 28, 2025 | 3.19 Bn |
| Jun 29, 2025 | 3.42 Bn |
| Mar 30, 2025 | 3.03 Bn |
| Sep 29, 2024 | 10.46 Bn |
| Jun 30, 2024 | 3.72 Bn |
| Mar 31, 2024 | 3.50 Bn |
| Dec 31, 2023 | 4.58 Bn |
| Jul 2, 2023 | 3.50 Bn |
| Apr 2, 2023 | 3.42 Bn |
| Jul 3, 2022 | 3.05 Bn |
| Apr 3, 2022 | 2.59 Bn |
| Oct 3, 2021 | 8.60 Bn |
| Jul 4, 2021 | 2.92 Bn |
| Apr 4, 2021 | 2.78 Bn |
| Sep 27, 2020 | 7.86 Bn |
| Jun 28, 2020 | 2.66 Bn |
| Mar 29, 2020 | 2.54 Bn |